For the Media
Dr. Seth Pollack is assistant member of Fred Hutch's Clinical Research Division in the Program in Immunology. He is an expert in sarcoma, cancer of the bone and soft tissues. His research is focused on developing new ways to enhance a patient's immune response against their cancer. He see's sarcoma patients at the Seattle Cancer Care Alliance, Fred Hutch's treatment arm.
Overview of Seth's Pollack's Research Focus
The Pollack Lab is the only laboratory in the world solely focused on harnessing the power of the immune system to cure sarcoma, a group cancers originating in bones and soft tissues. His lab takes a “two-pronged” approach to directing the immune system to fight these diseases:1) developing new ways to culture and engineer T cells with sarcoma specificity and 2) learning how to overcome the inhibitory effects of the sarcoma tumor microenvironments on what might otherwise be effective immunotherapies.
Seth Pollack- Brief Curriculum Vitae
Appointments, affiliations and researcher interests
Clinical Research Division
Researchers conduct laboratory and patient-oriented research to better understand the mechanisms that drive cancer and other human diseases. Integrating a variety of disciplines, our investigators are continually developing new therapeutic approaches and leading clinical trials that help move discoveries from laboratory to patient. Our pioneering research has saved hundreds of thousands of lives.
Program in Immunology
Program researchers continue to develop ways to make immunity-boosting therapies even more effective. They are showing these treatments can induce remissions for patients with advanced tumors and are likely to have broad utility across many cancers.
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first and largest cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Private contributions are essential for enabling Fred Hutch scientists to explore novel research opportunities that lead to important medical breakthroughs. For more information visit fredhutch.org or follow Fred Hutch on Facebook, Twitter or YouTube.